M12 M1 Beauty AG

DGAP-News: M1 Kliniken AG: Publishes consolidated financial statements 2019 - encouraging resumption of patient treatments - shortened notice periods for Annual General Meeting on 09 July 2020

DGAP-News: M1 Kliniken AG / Key word(s): Annual Results/Market Report
M1 Kliniken AG: Publishes consolidated financial statements 2019 - encouraging resumption of patient treatments - shortened notice periods for Annual General Meeting on 09 July 2020

20.05.2020 / 09:00
The issuer is solely responsible for the content of this announcement.


M1 Kliniken AG publishes consolidated financial statements 2019 - encouraging resumption of patient treatments - shortened notice periods for Annual General Meeting on 09 July 2020

- Consolidated sales +18 % to 77.2 million euros; consolidated net income +47 % to 9.7 million euros

- Positive development after resumption of patient treatment

- Annual General Meeting still scheduled for 9.07.2020 - shortened deadlines

Berlin, 20.05.2020 - M1 Kliniken AG (ISIN: DE000A0STSQ8) today published its consolidated financial statements for 2019. The M1 Group has increased its consolidated revenue by 18 % to EUR 77.2 million (previous year: EUR 65.2 million) in the financial year 2019. The consolidated net profit for the year increased by 47 % to 9.7 million euros (previous year: 6.6 million euros). The consolidated financial statements for 2019 were adopted by the Supervisory Board in its meeting on 20 April 2020.

The 2019 annual report of M1 Kliniken AG available for download: -kliniken.de

After the M1 Group had to temporarily close its practices and clinics in Germany and abroad on 23 March 2020, the majority of sites have now been reopened on the basis of a strict hygiene concept. Despite extended treatment intervals, a turnover level comparable to the "pre-corona business volume" has been achieved in the first week. In addition, schedules are almost completely booked out for a period of several weeks. M1 therefore assumes that the closure period and other effects of the corona pandemic will not have a long-term and sustainable impact on the Group's business model.

According to current planning, the Annual General Meeting of M1 Kliniken AG is still scheduled to take place on 9 July 2020. The Company is monitoring the development of the pandemic in order to decide whether to hold a 'classical' meeting or a virtual general meeting. For this purpose, the Company will work with shortened notice periods. The invitation to the Annual General Meeting will probably be published in the Federal Gazette ("Bundesanzeiger") towards the end of week 24.

About M1 Kliniken AG

M1 Kliniken AG is the leading provider of beauty medicine health services in Germany. In the aesthetic and surgical field, the group offers products and services of the highest quality. Under the brand M1 Med Beauty beauty medical treatments are currently offered at more than 35 locations. The M1 Schlossklinik for plastic and aesthetic surgery in Berlin, with six operating theatres and 35 beds, is one of the largest and most modern facilities of its kind in Europe. Since the end of 2018, M1 has been pushing ahead with its international expansion and is currently active in Austria, Switzerland, the Netherlands, UK and Australia. The Group is now also growing in other European countries. It markets high-quality products to private customers, doctors, pharmacies and wholesalers under the M1 Select and M1 Aesthetics brands. -kliniken.de

Contact:
M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
T: +49 (0)30 347 47 44 14
M:


20.05.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
Germany
Phone: +49 (0)30 347 47 44 14
Fax: +49 (0)30 347 47 44 17
E-mail:
Internet: -kliniken.de
ISIN: DE000A0STSQ8
WKN: A0STSQ
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart, Tradegate Exchange
EQS News ID: 1050499

 
End of News DGAP News Service

1050499  20.05.2020 

fncls.ssp?fn=show_t_gif&application_id=1050499&application_name=news&site_id=research_pool
EN
20/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on M1 Beauty AG

 PRESS RELEASE

EQS-News: M1 Kliniken AG steigert operativen Gewinn (EBIT) um 71 % in ...

EQS-News: M1 Kliniken AG / Schlagwort(e): Quartalsergebnis/9-Monatszahlen M1 Kliniken AG steigert operativen Gewinn (EBIT) um 71 % in den ersten neun Monaten 2024 und bestätigt Mittelfristziele 19.11.2024 / 08:15 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.   M1 Kliniken AG steigert operativen Gewinn (EBIT) um 71 % in den ersten neun Monaten 2024 und bestätigt Mittelfristziele Konzern: Umsatz +8,7 % auf 257,22 Mio. EUR und EBIT +70,7 % auf 22,09 Mio. EUR Wachstumstreiber Beauty-Segment mit Umsatz +33,5 % auf 71,02 Mio. EUR EBIT...

 PRESS RELEASE

EQS-News: M1 Kliniken AG increases operating profit (EBIT) by 71% in t...

EQS-News: M1 Kliniken AG / Key word(s): Quarter Results/9 Month figures M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets 19.11.2024 / 08:15 CET/CEST The issuer is solely responsible for the content of this announcement.   M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets Group: sales +8.7% to EUR 257.22 million and EBIT +70.7% to EUR 22.09 million Beauty segment growth driver with sales +33.5% to EUR 71.02 million EBIT in the...

 PRESS RELEASE

EQS-News: Operating Profit (EBIT) almost doubled: M1 Kliniken AG also ...

EQS-News: M1 Kliniken AG / Key word(s): Half Year Results/Quarter Results Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024 03.09.2024 / 08:45 CET/CEST The issuer is solely responsible for the content of this announcement.   Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024   Group: sales +11.2% to EUR 167.7 million and EBIT +98.8% to EUR 14.5 million Earnings per share increased from EUR 0.17 to EUR 0.53 Beauty segment: sales +30.6% and EBIT +24.3% Profit...

 PRESS RELEASE

EQS-News: Operativer Gewinn (EBIT) fast verdoppelt: M1 Kliniken AG wäc...

EQS-News: M1 Kliniken AG / Schlagwort(e): Halbjahresergebnis/Quartalsergebnis Operativer Gewinn (EBIT) fast verdoppelt: M1 Kliniken AG wächst auch in H1 2024 deutlich 03.09.2024 / 08:45 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.   Operativer Gewinn (EBIT) fast verdoppelt: M1 Kliniken AG wächst auch in H1 2024 deutlich   Konzern: Umsatz +11,2 % auf 167,7 Mio. EUR und EBIT +98,8 % auf 14,5 Mio. EUR Gewinn je Aktie von 0,17 EUR auf 0,53 EUR gesteigert Kernsegment Beauty: Umsatz +30,6 % und EBIT +24,3 % Profitables Wachstum ...

 PRESS RELEASE

EQS-News: M1 Kliniken AG: Vorstand bestätigt Wachstumsziele

EQS-News: M1 Kliniken AG / Schlagwort(e): Prognose M1 Kliniken AG: Vorstand bestätigt Wachstumsziele 21.06.2024 / 12:47 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. M1 Kliniken AG: Vorstand bestätigt Wachstumsziele Berlin, 21.06.2024 – Wie am 20.06.2024 gemeldet, hat Vorstand Attila Strauss einen Teil seiner Beteiligung an der M1 Kliniken AG (ISIN: DE000A0STSQ8) aus persönlichen finanziellen Gründen verkauft. Herr Strauss ist weiterhin mit über 2,3 % spürbar an der M1 Kliniken AG beteiligt. Attila Strauss betont: „Ich verstehe, d...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch